Allen, Azar & Troy: FDA Legal Partners Streamline Enforcement Activity
This article was originally published in The Tan Sheet
Executive Summary
HHS' decision to elevate FDA warning letter oversight from the Office of Regulatory Affairs to the Office of the Chief Counsel signals an attempt to keep a tighter rein on the agency in the absence of a commissioner
You may also be interested in...
FDA Chief Counsel Bradshaw Brings DoJ Experience
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel
FDA Chief Counsel Bradshaw Brings DoJ Experience
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel
FDA Chief Counsel Bradshaw Brings DoJ Experience
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel